Boutique founded by Anton Tagliaferro and Simon Conn launches on SS&C's institutional-quality fund administration and unit registry platform SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) today announced that Fundamental Investment Management (FIM), a Sydney-based boutique investment management firm, has selected SS&C to support its inaugural Fundamental Smaller Companies Fund. The Fund, launched in July, seeks to deliver long-term returns for investors by applying a research-driven value strategy to investing in Australian smaller companies. SS&C will provide fund administration and unit registry services for the Fund. MSC Trustees will serve as trustee and custodian. FIM specializes
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Fundamental Investment Management Chooses SS&C for Launch of Australian Small-Cap Fund
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 DateTotal number of sharesTotal number of voting rights08/31/2026 314,388,807 Total gross of voting rights: 314,388,807 Total net* of voting rights: 314,222,095 * Net total = total number of voting rights attached to shares – shares without voting rights Attachment PDF Version
- New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
Results support the clinical rationale for RASolve 301, an ongoing Phase 3 trial in RAS mutant metastatic non-small cell lung cancer REDWOOD CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers, today announced that The New England Journal of Medicine (NEJM) has published a report describing data from the Phase 1/2 clinical trial evaluating RASONQUE (daraxonrasib), an oral, RAS(ON) multi-selective inhibitor, in patients with previously treated advanced RAS mutant non-small cell lung cancer (NSCLC)
- Walker & Dunlop Arranges $390 Million Construction Financing for Park Tower in Jersey City
Walker & Dunlop, Inc. announced today that it has arranged $390,000,000 in construction financing for Park Tower, a new Class A mixed-use multifamily development in Jersey City’s Journal Square neighborhood. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902297145/en/Park Tower. Photo Credit: Namdar Group Walker & Dunlop Capital Markets Institutional Advisory arranged the loan as exclusive advisor to Namdar Group. Aaron Appel, Keith Kurland, Jonathan Schwartz, Adam Schwartz, Dustin Stolly, Sean Reimer, Jordan Casella, Christopher de Raet, and Edward Leboyer arranged the floating-rate, interest-only senior construction loan fr
- Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study Conducted by Akeso in China
Summit is Conducting HARMONi-7 in Patients with PD-L1 High-Expressing NSCLC Summit Therapeutics Inc. (NASDAQ:SMMT) today noted that its partner Akeso Inc. announced positive overall survival (OS) results from the randomized, double-blind Phase III HARMONi-2 study evaluating ivonescimab monotherapy against pembrolizumab monotherapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have positive PD-L1 expression. HARMONi-2 (AK112-303) is a single-region, multi-center Phase III study conducted in China and sponsored by Akeso, with all relevant data exclusively generated, managed, and analyzed by Akeso. In this preplanned analysis of OS, a secon
- Royal Bank of Canada to redeem NVCC subordinated debentures
TORONTO, Sept. 2, 2026 /CNW/ -- Royal Bank of Canada (TSX: RY) (NYSE:RY) today announced its intention to redeem all outstanding Non-Viability Contingent Capital (NVCC) 2.14 per cent subordinated debentures due November 3, 2031 for 100 per cent of their principal amount plus accrued interest to, but excluding, the redemption date. The redemption will occur on November 3, 2026. The current principal amount of 2.14 per cent NVCC subordinated debentures outstanding is $1,750,000,000. The redemption of the debentures will be financed out of the general corporate funds of Royal Bank of Canada.For further information, please contact:
- Virtus Convertible & Income Fund Announces Quarterly Distribution: 5.625% Series A Cumulative Preferred Shares
Virtus Convertible & Income Fund (NYSE:NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on September 30, 2026 to Series A cumulative preferred shareholders of record on September 23, 2026. The Series A Cumulative Preferred Shares, which trade on the New York Stock Exchange under the symbol NCV PR A, are rated "A" by Fitch Ratings and have an annual dividend rate of $1.40625 per share. The 4,000,000 Series A Cumulative Preferred Shares were issued September 20, 2018 at $25.00 per share and pay distributions quarterly. This distribution represents the accrual period from July 1, 2026 through September 30, 2026. The Series A Cumulative Preferred Shar
- Nu Holdings Announces Investor Day for December 8, 2026
Nu Holdings Ltd. ("Nu" or the "Company") (NYSE:NU), one of the world's largest digital banking platforms, today announced that it will host its first Investor Day on Tuesday, December 8, 2026, in New York City, with both in-person and virtual attendance available. The event will feature presentations by David Vélez, Founder and global Chief Executive Officer, and other members of Nu's senior management team, covering the Company's long-term strategy, growth opportunities, and drivers of value creation across its markets. Registration details and the full agenda will be shared closer to the event. A live webcast and supporting materials will be available at investors.nu, with a replay po
- BioRestorative Therapies Announces Reverse Stock Split
MELVILLE, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (NASDAQ:BRTX) ("BioRestorative" or the "Company"), a late-stage clinical regenerative medicine company, today announced that the Company’s Board of Directors approved a 1-for-20 reverse stock split (the "Reverse Stock Split") of the Company’s common stock (the "Common Stock"). The Company was not required to obtain stockholder approval to effectuate the Reverse Stock Split under Nevada law. The Company filed a certificate of change with the Secretary of State of the State of Nevada, which is expected to become effective as of 4:30 P.M. Eastern Time on September 7, 2026. The Common Stock will begin trading on
- Bank of Montreal Receives Regulatory Approvals for Normal Course Issuer Bid
TORONTO, Sept. 2, 2026 /CNW/ -- Bank of Montreal (TSX:BMO) (NYSE:BMO) today announced that it has received approvals from the Toronto Stock Exchange (TSX) and the Office of the Superintendent of Financial Institutions Canada (OSFI) to proceed with its previously-announced normal course issuer bid to purchase, for cancellation, up to 25 million of its common shares, commencing September 8, 2026, and ending no later than September 7, 2027. Purchases under the bid may be made through the facilities of the TSX and may also be made through other designated exchanges and alternative Canadian trading systems or by such other means as may be permitted by a securities regulatory authority, including
- Virtus Total Return Fund Inc. Announces Distributions
Virtus Total Return Fund Inc. (NYSE:ZTR) today announced the following monthly distributions: Ticker Amount of Distribution Ex-Date/Record Date Payable Date ZTR $0.055 September 14, 2026 September 29, 2026 ZTR $0.055 October 13, 2026 October 29, 2026 ZTR $0.055 November 12, 2026 November 27, 2026 Under the terms of its Managed Distribution Plan, the Fund will seek to maintain a consistent distribution level that may be paid, in part or in full, from net investment income and realized capital gains, or a combination thereof. Shareholders should note, however, that if the Fund's aggregat
- Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031
DALLAS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Capital Southwest Corporation ("Capital Southwest") (NASDAQ:CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced an amendment to its senior secured credit facility (the "Corporate Credit Facility"). The amendment (a) increased commitments under the Corporate Credit Facility from $510 million to $595 million, (b) decreased the applicable margin from 2.15% to 2.00%, (c) removed the SOFR adjustment, (d) increased the uncommitted accordion feature that could increase the maximum commitments from $750 million to $1 b
- Sempra Declares Common Dividend
SAN DIEGO, Sept. 2, 2026 /PRNewswire/ -- Sempra (NYSE:SRE) today announced that its board of directors has declared a $0.6575 per share quarterly dividend on the company's common stock, which is payable Oct. 15, 2026, to common stock shareholders of record at the close of business on Sept. 24, 2026.About SempraSempra's mission is to build America's leading utility growth business. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving energy resilience in California and Texas, the two largest economies in the U.S. The company is recognized as a leader in responsible business practices and for its high-performance culture focused on safety and op
- Amkor Technology to Present at the Goldman Sachs Communacopia + Technology Conference
Amkor Technology, Inc. (NASDAQ:AMKR), a leading provider of semiconductor packaging and test services, today announced that it will participate in the Goldman Sachs Communacopia + Technology Conference on Wednesday, September 9, 2026. Amkor’s presentation will occur at 8:10 am Pacific Time (11:10 am Eastern Time) in San Francisco, CA. A webcast and replay of the presentation will be made available on the Investor Relations section of Amkor’s website, located at ir.amkor.com. Management will also be available for one-on-one and small group meetings with investors. About Amkor Technology, Inc. Amkor Technology, Inc. (NASDAQ:AMKR) is the world’s largest U.S. headquartered OSAT and is a g
- Shell completes acquisition of ARC Resources
CALGARY, AB, Sept. 2, 2026 /CNW/ -- Shell plc has completed the previously announced agreement (the "Arrangement Agreement") to acquire ARC Resources Ltd. ("ARC") (TSX:ARX), an energy company focused in British Columbia and Alberta, Canada, following receipt of all required shareholder, court and regulatory approvals. The acquisition accelerates Shell's strategy by adding approximately 370 kboe/d immediately across liquids and gas, supporting a production compound annual growth rate (CAGR) of around 4% through to 2030 compared with 2025. "Today we welcome ARC colleagues to Shell and look forward to building on their high-perfor
- Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC
CLAYMONT, Del., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (NASDAQ:ATII), a publicly traded special purpose acquisition company ("ATII" or "Archimedes II"), today announced the filing with the U.S. Securities and Exchange Commission (the "SEC"), on September 2, 2026, of an amendment to the registration statement on Form S-4 (File No.: 333-295563) (as may be amended from time to time, the "Registration Statement") previously filed in connection with the previously announced proposed business combination with Forge Nano, Inc. ("Forge Nano"). The Registration Statement includes a preliminary proxy statement/prospectus and has not yet been declared effective. The R
- Novavax to Participate in September Investor Conferences
GAITHERSBURG, Md., Sept. 2, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced that company management will participate in the following upcoming investor conferences:2026 Cantor Global Healthcare Conference, New YorkFireside chat on Wednesday, September 9, 2026, at 9:45 a.m. EDTCiti's 2026 BioPharma Back to School Conference, New YorkFireside chat on Thursday, September 10, 2026, at 10:00 a.m. EDTA live webcast of the fireside chats will be available on the "Events & Presentations" page of the Company's website at ir.novavax.com. A replay of each webcast will be available for 30 days following the presentation.About NovavaxNovavax, Inc. (NASDAQ:NVAX) tackles some of the world'
- Prologis Declares Quarterly Dividend
SAN FRANCISCO, September 2, 2026 /PRNewswire/ -- The Board of Directors of Prologis, Inc. (NYSE:PLD) declared a regular cash dividend for the quarter ending September 30, 2026, on the following securities:A dividend of $1.07 per share of the company's common stock, payable on September 30, 2026, to common stockholders of record at the close of business on September 16, 2026; andA dividend of $1.0675 per share of the company's 8.54% Series Q Cumulative Redeemable Preferred Stock, payable on September 30, 2026, to Series Q stockholders of record at the close of business on September 16, 2026.ABOUT PROLOGISThe world runs on logistics. At Prologis, we don't just lead the industry, we define it.
- NexPoint Diversified Real Estate Trust Announces Investor Update Call
DALLAS, Sept. 2, 2026 /PRNewswire/ -- NexPoint Diversified Real Estate Trust ("NXDT") (NYSE:NXDT) announced today that the Company is scheduled to host a conference call on Thursday, September 24, 2026, at 11:00 a.m. ET (10:00 am CT), to discuss portfolio updates and recent performance. The conference call can be accessed live over the phone by dialing 833-461-5787 or, for international callers, +1 365-657-4084 and using passcode Conference ID: 274211798. A live audio webcast of the call will be available online at the Company's website, https://nxdt.nexpoint.com (under "Resources"). An online replay will be available shortly a
- Highland Opportunities and Income Fund Announces Investor Update Call
DALLAS, Sept. 2, 2026 /PRNewswire/ -- The Highland Opportunities and Income Fund (NYSE:HFRO) ("HFRO" or the "Fund") announced today that the Fund is scheduled to host a conference call on Thursday, September 25, 2026, at 3:00 p.m. CT, to discuss portfolio updates and recent performance. To register to attend the call click here or visit Highland Opportunities and Income Fund Website and follow the link to register.Attendees may submit questions ahead of the call. Questions can be submitted through the registration link. A replay will be available on HFRO's website after the call.About the Highland Opportunities and Income FundThe Highland Opportunities and Income Fund (NYSE: HFRO) is a close